On behalf of Leyden Labs, Koenraad Wiedhaup (CEO), Clarissa Koch (CSO), and Rosemary Tan (CEO, Leyden Labs Asia) recently met with leaders from the International Vaccine Institute, Temasek Trust, and Temasek Foundation in Seoul, South Korea to explore new approaches to infectious disease prevention.

Discussions focused on applying Leyden Labs’ mucosal protection platform to improve protection against viruses such as influenza and measles. Research and leadership teams explored how they could contribute to this shared mission.

The visit marked the start of a new partnership, formalized through a memorandum of understanding to combine their expertise and capabilities.